Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma

References

• Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304.
   PubMed Web of Science ®Google Scholar
• Bai J, Xie Z, Sun L. Case report: metachronous quadruple cancers including breast cancer and triple genital cancer. Int J Gen Med. 2020;13:1575–1580. doi:10.2147/IJGM.S278219
   PubMed Web of Science ®Google Scholar
• Hidayat YM, Munizar HAB, Winarno GNA, Hasanuddin SS. Chemokine ligand 5 to predict optimal cytoreduction in ovarian cancer. Int J Gen Med. 2020;13:1201–1206. doi:10.2147/IJGM.S280858
   PubMed Web of Science ®Google Scholar
• Nesic K, Kondrashova O, Hurley RM, et al. Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high-grade serous ovarian carcinoma. Cancer Res. 2021;81:4709–4722. doi:10.1158/0008-5472.CAN-21-0774
   PubMed Web of Science ®Google Scholar
• Wan X, Zhang H, Zhang Y, Peng Y. Metastases to the breast from extramammary nonhematological malignancies: case series. Int J Gen Med. 2020;13:1105–1114. doi:10.2147/IJGM.S276602
   PubMed Web of Science ®Google Scholar
• Li FL, Guan KL. The two sides of Hippo pathway in cancer. Semin Cancer Biol. 2021. doi:10.1016/j.semcancer.2021.07.006
   Web of Science ®Google Scholar
• Liu Y, Zhang Q, Wu J, et al. Long non-coding RNA A2M-AS1 promotes breast cancer progression by sponging microRNA-146b to upregulate MUC19. Int J Gen Med. 2020;13:1305–1316. doi:10.2147/IJGM.S278564
   PubMed Web of Science ®Google Scholar
• Xue C, Liu X, Wen B, et al. Zebrafish vestigial like family member 4b is required for valvulogenesis through sequestration of transcription factor myocyte enhancer factor 2c. Front Cell Develop Biol. 2019;7:277. doi:10.3389/fcell.2019.00277
   PubMed Web of Science ®Google Scholar
• Yamaguchi N. Multiple roles of vestigial-like family members in tumor development. Front Oncol. 2020;10:1266. doi:10.3389/fonc.2020.01266
   PubMed Web of Science ®Google Scholar
• He Z, Li R, Jiang H. Mutations and copy number abnormalities of hippo pathway components in human cancers. Front Cell Develop Biol. 2021;9:661718. doi:10.3389/fcell.2021.661718
   PubMed Web of Science ®Google Scholar
• Qu L, Wu Z, Li Y, et al. A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells. Nat Commun. 2016;7:12692. doi:10.1038/ncomms12692
   PubMed Web of Science ®Google Scholar
• Kalayci M, Hassan IA, Keinan IA, et al. The effect of hemodialysis on axial length, ocular surface, and intraocular pressure in patients with end-stage renal failure. Int J Gen Med. 2020;13:1035–1042. doi:10.2147/IJGM.S281546
   PubMed Web of Science ®Google Scholar
• Wang X, Wang S, Pang YP, et al. Contrast-enhanced ultrasound assessment of renal parenchymal perfusion in patients with atherosclerotic renal artery stenosis to predict renal function improvement after revascularization. Int J Gen Med. 2020;13:1713–1721. doi:10.2147/IJGM.S293316
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Zhang K, Yang M, Hu X. GE-mini: a mobile APP for large-scale gene expression visualization. Bioinformatics. 2017;33(6):941–943.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/S1476-5586(04)80047-2
   PubMed Web of Science ®Google Scholar
• Gyorffy B, Gyorffy A, Tulassay Z. [The problem of multiple testing and solutions for genome-wide studies]. Orv Hetil. 2005;146(12):559–563. Danish.
   PubMedGoogle Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368. doi:10.1093/nar/gkw937
   PubMed Web of Science ®Google Scholar
• Wang J, Vasaikar S, Shi Z, Greer M, Zhang B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 2017;45(W1):W130–W137. doi:10.1093/nar/gkx356
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Currey L, Thor S, Piper M. TEAD family transcription factors in development and disease. Development. 2021;148(12). doi:10.1242/dev.196675
   PubMed Web of Science ®Google Scholar
• Brunty S, Mitchell B, Bou-Zgheib N, Santanam N. Endometriosis and ovarian cancer risk, an epigenetic connection. Ann Transl Med. 2020;8(24):1715. doi:10.21037/atm-20-2449
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhang Q, Yuan W, et al. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis. J Exp Clin Cancer Res. 2020;39(1):250. doi:10.1186/s13046-020-01705-9
   PubMed Web of Science ®Google Scholar
• Demircan NC, Boussios S, Tasci T, Ozturk MA. Current and future immunotherapy approaches in ovarian cancer. Ann Transl Med. 2020;8(24):1714. doi:10.21037/atm-20-4499
   PubMed Web of Science ®Google Scholar
• Joo JS, Cho SY, Rou WS, et al. TEAD2 as a novel prognostic factor for hepatocellular carcinoma. Oncol Rep. 2020;43(6):1785–1796.
   PubMed Web of Science ®Google Scholar
• Samartzis EP, Labidi-Galy SI, Moschetta M, et al. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review. Ann Transl Med. 2020;8(24):1712. doi:10.21037/atm-20-3022a
   PubMed Web of Science ®Google Scholar
• Liu J, Zhao X, Wang K, et al. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma. Cell Death Dis. 2019;10(6):452. doi:10.1038/s41419-019-1674-2
   PubMed Web of Science ®Google Scholar
• Tang R, Hua J, Xu J, et al. The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer. Ann Transl Med. 2020;8(21):1347. doi:10.21037/atm-20-2554a
   PubMed Web of Science ®Google Scholar
• Yu T, Song J, Zhou H, et al. Nuclear TEAD4 with SIX1 overexpression is an independent prognostic marker in the stage I-III colorectal cancer. Cancer Manag Res. 2021;13:1581–1589. doi:10.2147/CMAR.S260790
   PubMed Web of Science ®Google Scholar
• Valpione S, Mundra PA, Galvani E, et al. The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival. Nat Commun. 2021;12(1):4098. doi:10.1038/s41467-021-24343-x
   PubMed Web of Science ®Google Scholar
• Brase JC, Walter RFH, Savchenko A, et al. Role of tumor-infiltrating B cells in clinical outcome of patients with melanoma treated with dabrafenib plus trametinib. Clin Cancer Res. 2021;27:4500–4510. doi:10.1158/1078-0432.CCR-20-3586
   PubMed Web of Science ®Google Scholar
• Mhaidly R, Mechta-Grigoriou F. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer. Immunol Rev. 2021;302(1):259–272. doi:10.1111/imr.12978
   PubMed Web of Science ®Google Scholar
• Le Saux O, Ray-Coquard I, Labidi-Galy SI. Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer. Semin Cancer Biol. 2020. doi:10.1016/j.semcancer.2020.08.017
   PubMed Web of Science ®Google Scholar
• Fucikova J, Rakova J, Hensler M, et al. TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer. Clin Cancer Res. 2019;25(15):4820–4831. doi:10.1158/1078-0432.CCR-18-4175
   PubMed Web of Science ®Google Scholar
• Mesnage SJL, Auguste A, Genestie C, et al. Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). Ann Oncol. 2017;28(3):651–657. doi:10.1093/annonc/mdw625
   PubMed Web of Science ®Google Scholar
• Laumont CM, Wouters MCA, Smazynski J, et al. Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer. Clin Cancer Res. 2021;27(14):4089–4100. doi:10.1158/1078-0432.CCR-20-4394
   PubMed Web of Science ®Google Scholar
• Xu R, Wu M, Liu S, et al. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) Treg cells in ovarian cancer cells microenvironment. Cell Death Dis. 2021;12(1):22. doi:10.1038/s41419-020-03272-5
   PubMed Web of Science ®Google Scholar
• Wei J, Xie Q, Liu X, et al. Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med. 2020;8(11):678. doi:10.21037/atm-20-3296
   PubMed Web of Science ®Google Scholar
• Liu QF, Feng ZY, Jiang LL, Xu TT, Li SM, Liu KR. Immune cell infiltration as signatures for the diagnosis and prognosis of malignant gynecological tumors. Front Cell Develop Biol. 2021;9:702451. doi:10.3389/fcell.2021.702451
   PubMed Web of Science ®Google Scholar
• Liu R, Hu R, Zeng Y, Zhang W, Zhou HH. Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: a gene expression-based computational study. EBioMedicine. 2020;51:102602. doi:10.1016/j.ebiom.2019.102602
   PubMed Web of Science ®Google Scholar
• Wei R, Qiu H, Xu J, et al. Expression and prognostic potential of GPX1 in human cancers based on data mining. Ann Transl Med. 2020;8(4):124. doi:10.21037/atm.2020.02.36
   PubMed Web of Science ®Google Scholar